A quick overview of the Hong Kong market | Hong Kong stocks are rising across the board! The Tech Index surged more than 3%, Kuaishou surged nearly 9%, and Meituan rose nearly 8%

Many biotech stocks rose; Lai Kai Pharmaceutical rose nearly 13%, Kangfang Biotech rose nearly 6%; gold stocks declined, Lingbao Gold fell nearly 4%, and Zijin Mining fell more than 3%.

Futu NewsApr 23 16:27

Changes in Hong Kong stocks | Pharmaceutical stocks strengthened in the afternoon, and the innovative drug policy showed a positive trend, and the sector is expected to continue to warm up after the second quarter

Pharmaceutical stocks strengthened in the afternoon. As of press release, Laikai Pharmaceutical-B (02105) rose 13.67% to HK$6.07; Conoa-B (02162) rose 13.21% to HK$33; and Pharmaceuticals (02268) rose 7.52% to HK$20.15.

Zhitong FinanceApr 23 13:55 · Movers

Changes in Hong Kong stocks | Pharmaceutical Federation (02268) is now up more than 6%, and the company's performance is doubling, and global production capacity is being released at an accelerated pace

Pharmaceutical Federation (02268) is now up more than 6%. As of press release, it is up 6.51% to HK$19.96, with a turnover of HK$488.745 million.

Zhitong FinanceApr 23 11:11

Most of the Hong Kong pharmaceutical stocks rose, and Pharmacovigilance rose nearly 9%

As of press release, Pharmacomide is up 8.86%, Cansino Biotech is up 5.26%, and Medicinal Kangde is up 2.85%.

Zhitong FinanceApr 23 09:49

Big benefits have arrived! Pharmacovigilance is getting stronger. What's the situation?

Yao Ming Kangde's deep participation in the US healthcare field has far surpassed congressional discussions. Some senior members of the country's biotech industry have clearly opposed the bill.

券商中國Apr 17 16:06

Changes in Hong Kong stocks | Yao Ming Union (02268) surged more than 5% in the afternoon, and the company achieved a further breakthrough in the ADC CRDMO business after the listing

The Zhitong Finance App learned that Yao Ming United (02268) surged by more than 5% in the afternoon. As of press release, it had risen 5.01% to HK$17.6 million, with a turnover of HK$2016.67 million. Guoxin Securities pointed out that as the ADC CRDMO leader with a global layout, Pharmaceutical Federation has established a fully integrated one-stop CRDMO platform, covering the entire ADC CRDMO service process and leading the world in comprehensive capabilities. As the company's global production capacity continues to expand and pre-IND projects continue to advance to the post-IND stage, we believe that the company's business will maintain rapid growth over the next 3 years. Tianfeng Securities, on the other hand, said that

Zhitong FinanceApr 17 14:19